Bjelovic Milos, Gunjic Dragan, Babic Tamara, Veselinovic Milan, Djukanovic Marija, Potkonjak Dario, Milosavljevic Vladimir
Euromedic General Hospital, Bulevar umetnosti 29, 11070 Belgrade, Serbia.
School of Medicine Foca, University East Sarajevo, Studentska 5, 73300 Foca, Bosnia and Herzegovina.
J Clin Med. 2024 Jul 26;13(15):4364. doi: 10.3390/jcm13154364.
The global shift from open esophagectomy (OE) to minimally invasive esophagectomy (MIE) for treating esophageal cancer is well-established. Recent data indicate that transitioning from hybrid minimally invasive esophagectomy (hMIE) to total minimally invasive esophagectomy (tMIE) can be challenging due to concerns about higher leakage rates and lower lymph node counts, especially at the beginning of the learning curve. This study aimed to demonstrate that a safe transition from OE to tMIE for cancer is possible using process management methodology. Methods: A step-change approach was adopted in process management planning, with hMIE serving as an intermediate step between OE and tMIE. This single-center, case-control study included 150 patients who underwent the Ivor Lewis procedure with curative intent for esophageal cancer. Among these patients, 50 underwent OE, 50 hMIE (laparoscopic procedure followed by conventional right thoracotomy), and 50 tMIE (laparoscopic and thoracoscopic approach). A preceptored training scheme was implemented during execution, and treatment results were monitored and controlled to ensure a safe transition. Results: During the transition, the tMIE group was not worse than the hMIE and OE groups regarding operation duration ( = 0.135), overall postoperative complications ( = 0.020), anastomotic leakage rates ( = 0.773), 30-day mortality ( = 1.0), and oncological outcomes (based on R status ( = 0.628) and 2-year survival ( = 0.967)). Additionally, the tMIE group showed superior results in terms of major postoperative pulmonary complications ( = 0.004) and ICU stay duration ( < 0.001). Utilizing managerial methodology and practice in surgery, as a bridge between interdisciplinary and transdisciplinary approaches, demonstrated that transitioning from OE to tMIE, with hMIE as an intermediate step, is safe and feasible without compromising outcomes.
全球范围内,治疗食管癌从开放食管切除术(OE)向微创食管切除术(MIE)的转变已得到充分确立。近期数据表明,从杂交微创食管切除术(hMIE)过渡到完全微创食管切除术(tMIE)可能具有挑战性,因为担心渗漏率较高和淋巴结计数较低,尤其是在学习曲线开始阶段。本研究旨在证明使用流程管理方法,从OE安全过渡到tMIE治疗癌症是可行的。方法:在流程管理规划中采用逐步变化的方法,将hMIE作为OE和tMIE之间的中间步骤。这项单中心病例对照研究纳入了150例接受Ivor Lewis手术、旨在根治食管癌的患者。在这些患者中,50例行OE,50例行hMIE(腹腔镜手术随后进行传统右胸切开术),50例行tMIE(腹腔镜和胸腔镜手术)。在实施过程中采用了带教培训方案,并对治疗结果进行监测和控制,以确保安全过渡。结果:在过渡期间,tMIE组在手术持续时间(=0.135)、总体术后并发症(=0.020)、吻合口漏率(=0.773)、30天死亡率(=1.0)和肿瘤学结局(基于R状态(=0.628)和2年生存率(=0.967))方面并不比hMIE组和OE组差。此外,tMIE组在术后主要肺部并发症(=0.004)和重症监护病房停留时间(<0.001)方面表现更优。在手术中运用管理方法和实践,作为跨学科和跨领域方法之间的桥梁,证明了以hMIE作为中间步骤从OE过渡到tMIE是安全可行的,且不影响治疗效果。